Again only the common type of MS gets research into drugs
'Multiple sclerosis drugs should be offered earlier'
People with the most common form of multiple sclerosis should be offered drug treatment earlier, a charity says.
The Multiple Sclerosis Society's report suggests there is a "wait-and-see" approach by doctors which needs to end.
But drug watchdog NICE says while this "disease-modifying therapy" can help in some cases, the benefits need to be weighed carefully against side-effects.
It is reviewing exactly when and how some of these relatively new treatments should be used.
'Clock never stops'
Multiple sclerosis (MS) is an incurable condition that can lead to sight loss, pain, fatigue and disability. It affects around 100,000 people in the UK.
Many have a relapsing, remitting version - where they experience flare-ups of symptoms and then have periods where symptoms ease or disappear.
http://www.bbc.co.uk/news/health-34392429